
    
      Evaluate clinical efficacy, microbiological efficacy and safety of Nemonoxacin adult patients
      with community-acquired pneumonia (CAP); and

      A study on the population pharmacokinetics (PPK) of continuous oral administration of
      Nemonoxacin in adult patients with CAP.
    
  